Precision NanoSystems has launched the NanoAssemblr™ Scale-Up system to support the clinical development of nanomedicines. This latest addition to the NanoAssemblr range is designed for the ...

VANCOUVER, June 7, 2018 /CNW/ - Precision NanoSystems (PNI) today announced that it has closed a US$6M Series B investment. The funds will be used to expand PNI's products and services globally and to ...

VANCOUVER, Nov. 13, 2018 /CNW/ - Precision NanoSystems, Inc. (PNI) and Entos Pharmaceuticals (Entos) today announced they have entered into a license and supply agreement whereby PNI will provide its ...

Cytiva has launched the NanoAssemblr commercial formulation system, purpose-built for clinical and commercial manufacturing of lipid nanoparticle medicines. Fully compliant and offering automated ...

Precision NanoSystems NanoAssemblr™ platform has been selected for the controlled manufacture of nanomedicines as part of the multinational B-SMART (Brain-Specific, Modular and Active RNA Therapeutics ...

Precision NanoSystems empowers researchers to develop genetic medicines through its NanoAssmblr technology, helping companies solve drug delivery challenges in both cancer and infectious diseases.

EDMONTON, Alberta, May 7, 2020 -- Entos Pharmaceuticals (Entos), a healthcare biotechnology company developing next generation nucleic acid medicines with their Fusogenix delivery platform announced ...

How will Google Life Sciences create its highly anticipated nanotech diagnostic hordes? Precision NanoSystems might know. It's nabbed a $13.4 million Series A round to back its NanoAssemblr platform ...

VANCOUVER, British Columbia, Aug. 18, 2016 /PRNewswire/ -- Precision NanoSystems, Inc. (PNI), a biotechnology company dedicated to helping advance nanotechnology solutions for the molecular ...

Touching Base is the dynamic podcast series from the editors of GEN. Each episode features a rotating case of senior editors—including John Sterling, Kevin Davies, Julianna LeMieux, Alex Phillippidis, ...